4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-025445
SVP & Chief Accounting Officer sold 13,881 shares at $101.46 ($1,408,366)
- SVP & Chief Accounting Officer acquired 13,881 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2018-04-16 | Option exercise | +13,881 | $10.69 | $148,388 | 82,738 | D: show line 1 in the form |
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2018-04-16 | Sale | −13,881 | $101.46 | $1,408,366 | 68,857 | D: show line 2 in the form |
| Open-market sales · 13,881 sh · avg $101.46 · $1,408,366 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2018-04-16 | Option exercise · Stock Option | −13,881 | 16,119 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…